Simulations Plus SLP 深沪

等待开盘 08-10 09:30:00 美东时间

18.32

-0.020

-0.11%

华盛通

立即下载

最高18.36
今开18.32
成交量 15.50万股
最低 18.29
昨收 18.34
总市值 37.02万
52周最高 21.01
市盈率 ^静 38.85
换手率 767.05%
52周最低 11.09
委比 -27.14%
总股本 2.02万
历史最高 90.62
量比 0.80
振幅 0.38%
历史最低 0.52
每手 1
风险率 2.50%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Dow Gains 50 Points; Simulations Plus Earnings Top Views

Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares jumped 0.9% while health care fell 0.5%. Simulations Plus Inc beats earnings estimates, WD-40 Co and Jiuzi Holdings Inc see gains, eLong Power Holding Ltd and Virax Biolabs Group Ltd see losses. European shares mixed, Asian markets close mixed.

07-11 00:38
Earnings Scheduled For July 9, 2026

Companies Reporting Before The Bell • Simply Good Foods (NASDAQ:SMPL) is likely to report quarterly earnings at $0.35 per share on revenue of $332.35 million. • PepsiCo (NASDAQ:PEP) is likely to report quarterly

07-09 19:11
Simulations Plus Agrees To Be Acquired By Altaris For $18.50/Share

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it has entered

06-16 21:01
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push

Simulations Plus announces an Nvidia deal to accelerate AI drug modeling, but weak growth and momentum metrics raise concerns about the long-term outlook.

05-06 23:50
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst

Certara stock rises after $135 million divestiture to Veristat as analysts weigh MIDD focus and improving biopharma demand.

04-23 03:23
Earnings Scheduled For January 8, 2026

Companies Reporting Before The Bell • Acuity (NYSE:AYI) is projected to report ...

01-08 19:11
This PayPal Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a comple...

2025-12-18 21:02
BTIG Downgrades Simulations Plus to Neutral

BTIG analyst David Larsen downgrades Simulations Plus (NASDAQ:SLP) from Buy to Neutral.

2025-12-18 20:16
Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound

Simulations Plus stock rises after beating earnings and reaffirming 2026 guidance as analysts highlight improving demand and long-term growth potential.

2025-12-03 01:52
Earnings Scheduled For December 1, 2025

Companies Reporting Before The Bell • Hafnia (NYSE:HAFN) is expected to report ...

2025-12-01 19:11

派息除权日	每股总股息	派息日期
2022-04-22	0.06	2022-05-02
2022-01-28	0.06	2022-02-07
2021-10-22	0.06	2021-11-01
2021-07-23	0.06	2021-08-02
2021-04-23	0.06	2021-05-03
2021-01-22	0.06	2021-02-01
2020-10-23	0.06	2020-11-02
2020-07-24	0.06	2020-08-03
2020-04-23	0.06	2020-05-01
2020-01-24	0.06	2020-02-03
2019-10-24	0.06	2019-11-01
2019-07-24	0.06	2019-08-01
2019-04-23	0.06	2019-05-01
2019-01-24	0.06	2019-02-01
2018-10-31	0.06	2018-11-08
2018-07-25	0.06	2018-08-02
2018-04-24	0.06	2018-05-02
2018-01-25	0.06	2018-02-02
2017-11-10	0.06	2017-11-20
2017-07-26	0.05	2017-08-04
2017-05-04	0.05	2017-05-15
2017-01-26	0.05	2017-02-06
2016-11-08	0.05	2016-11-17
2016-08-09	0.05	2016-08-18
2016-04-28	0.05	2016-05-09
2016-01-27	0.05	2016-02-05
2015-11-05	0.05	2015-11-16
2015-07-21	0.05	2015-07-30
2015-05-07	0.05	2015-05-18
2015-01-22	0.05	2015-02-02
2014-11-05	0.05	2014-11-14
2014-07-31	0.05	2014-08-11
2014-05-07	0.05	2014-05-16
2014-02-12	0.05	2014-02-24
2013-11-06	0.04	2013-11-15
2013-08-08	0.03	2013-08-15
2013-05-03	0.03	2013-05-10
2012-12-20	0.14	2012-12-28
2012-11-06	0.05	2012-11-13
2012-08-03	0.05	2012-08-10
2012-04-25	0.05	2012-05-08
2012-02-16	0.05	2012-03-01

公司名称	Simulations Plus
行业分类	医疗保健软件
业务描述	Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Simulations Plus SLP 深 沪

18.32

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Simulations Plus SLP 深沪